# An Open-label, Clinical Feasibility Study of the Efficacy of Remdesivir for Long-COVID.

> **NCT05911906** · PHASE4 · COMPLETED · sponsor: **University of Derby** · enrollment: 73 (actual)

## Conditions studied

- SARS-CoV-2 Infection
- COVID-19

## Interventions

- **DRUG:** Remdesivir

## Key facts

- **NCT ID:** NCT05911906
- **Lead sponsor:** University of Derby
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-08
- **Primary completion:** 2025-09-17
- **Final completion:** 2025-09-17
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05911906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05911906, "An Open-label, Clinical Feasibility Study of the Efficacy of Remdesivir for Long-COVID.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05911906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*